GALECTIN THERAPEUTICS INC. Research and Development Expense
GALECTIN THERAPEUTICS INC. (GALT) reported Research and Development Expense of $2.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- GALECTIN THERAPEUTICS INC. research and development expense for the quarter ending 2026-06-30 was $2.13M, a 34.53% decline year-over-year.
- GALECTIN THERAPEUTICS INC. research and development expense for the quarter ending 2026-03-31 was $2.23M, a 65.60% decline year-over-year.
- GALECTIN THERAPEUTICS INC. research and development expense for the quarter ending 2025-12-31 was $1.93M, a 82.60% decline year-over-year.
- GALECTIN THERAPEUTICS INC. research and development expense for the quarter ending 2025-09-30 was $2.61M, a 65.62% decline year-over-year.
- GALECTIN THERAPEUTICS INC. research and development expense for fiscal 2025 was $14.29M, a 60.93% decline from fiscal 2024.
- GALECTIN THERAPEUTICS INC. research and development expense for fiscal 2024 was $36.57M, a 13.82% increase from fiscal 2023.
- GALECTIN THERAPEUTICS INC. research and development expense for fiscal 2023 was $32.13M, a 1.24% increase from fiscal 2022.
- GALECTIN THERAPEUTICS INC. research and development expense for fiscal 2022 was $31.74M, a 33.25% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 132 month | Research and Development Expense 135 month | Research and Development Expense 138 month | Research and Development Expense 141 month | Research and Development Expense 144 month | Research and Development Expense 147 month | Research and Development Expense 150 month | Research and Development Expense 153 month | Research and Development Expense 156 month | Research and Development Expense 159 month | Research and Development Expense 162 month | Research and Development Expense 165 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.13M 10-Q · filed 2026-08-14 | $4.37M 10-Q · filed 2026-08-14 | $6.30M derived: sum of 3 quarters · filed 2026-08-14 | $8.91M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2026-03-31 | $2.23M 10-Q · filed 2026-05-15 | $4.16M derived: sum of 2 quarters · filed 2026-05-15 | $6.78M derived: sum of 3 quarters · filed 2026-05-15 | $10.04M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.54M derived: sum of 2 quarters · filed 2026-03-31 | $7.80M derived: sum of 3 quarters · filed 2026-08-14 | $14.29M 10-K · filed 2026-03-31 | ||||||||||||
| 2025-09-30 | $2.61M 10-Q · filed 2025-11-14 | $5.87M derived: sum of 2 quarters · filed 2026-08-14 | $12.36M 10-Q · filed 2025-11-14 | $23.47M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-06-30 | $3.26M 10-Q · filed 2026-08-14 | $9.75M 10-Q · filed 2026-08-14 | $20.86M derived: sum of 3 quarters · filed 2026-08-14 | $28.45M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||||||
| 2025-03-31 | $6.49M 10-Q · filed 2026-05-15 | $17.59M derived: sum of 2 quarters · filed 2026-05-15 | $25.19M derived: sum of 3 quarters · filed 2026-05-15 | $35.00M derived: sum of 4 quarters · filed 2026-05-15 | ||||||||||||
| 2024-12-31 | $11.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $18.70M derived: sum of 2 quarters · filed 2026-03-31 | $28.52M derived: sum of 3 quarters · filed 2026-03-31 | $36.57M 10-K · filed 2026-03-31 | ||||||||||||
| 2024-09-30 | $7.59M 10-Q · filed 2025-11-14 | $17.41M derived: sum of 2 quarters · filed 2025-11-14 | $25.46M 10-Q · filed 2025-11-14 | $33.69M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||||||
| 2024-06-30 | $9.81M 10-Q · filed 2025-08-14 | $17.87M 10-Q · filed 2025-08-14 | $26.09M derived: sum of 3 quarters · filed 2025-08-14 | $33.83M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||
| 2024-03-31 | $8.05M 10-Q · filed 2025-05-15 | $16.28M derived: sum of 2 quarters · filed 2025-05-15 | $24.01M derived: sum of 3 quarters · filed 2025-05-15 | $31.39M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||
| 2023-12-31 | $8.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $15.96M derived: sum of 2 quarters · filed 2025-03-31 | $23.33M derived: sum of 3 quarters · filed 2025-03-31 | $32.13M 10-K · filed 2025-03-31 | ||||||||||||
| 2023-09-30 | $7.73M 10-Q · filed 2024-11-14 | $15.10M derived: sum of 2 quarters · filed 2024-11-14 | $23.90M 10-Q · filed 2024-11-14 | $32.91M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||
| 2023-06-30 | $7.37M 10-Q · filed 2024-08-13 | $16.17M 10-Q · filed 2024-08-13 | $25.18M derived: sum of 3 quarters · filed 2024-08-13 | $31.77M derived: sum of 4 quarters · filed 2024-08-13 | ||||||||||||
| 2023-03-31 | $8.80M 10-Q · filed 2024-05-15 | $17.81M derived: sum of 2 quarters · filed 2024-05-15 | $24.40M derived: sum of 3 quarters · filed 2024-05-15 | $32.48M derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||||
| 2022-12-31 | $9.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $15.61M derived: sum of 2 quarters · filed 2024-03-29 | $23.68M derived: sum of 3 quarters · filed 2024-03-29 | $31.74M 10-K · filed 2024-03-29 | ||||||||||||
| 2022-09-30 | $6.60M 10-Q · filed 2023-11-13 | $14.67M derived: sum of 2 quarters · filed 2023-11-13 | $22.73M 10-Q · filed 2023-11-13 | $28.59M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-06-30 | $8.07M 10-Q · filed 2023-08-14 | $16.13M 10-Q · filed 2023-08-14 | $21.99M derived: sum of 3 quarters · filed 2023-08-14 | $28.60M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||
| 2022-03-31 | $8.06M 10-Q · filed 2023-05-15 | $13.91M derived: sum of 2 quarters · filed 2023-05-15 | $20.53M derived: sum of 3 quarters · filed 2023-05-15 | $26.98M derived: sum of 4 quarters · filed 2023-05-15 | ||||||||||||
| 2021-12-31 | $5.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $12.47M derived: sum of 2 quarters · filed 2023-03-30 | $18.92M derived: sum of 3 quarters · filed 2023-03-30 | $23.82M 10-K · filed 2023-03-30 | ||||||||||||
| 2021-09-30 | $6.61M 10-Q · filed 2022-11-14 | $13.06M derived: sum of 2 quarters · filed 2022-11-14 | $17.96M 10-Q · filed 2022-11-14 | $24.33M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | $6.45M 10-Q · filed 2022-08-15 | $11.35M 10-Q · filed 2022-08-15 | $17.72M derived: sum of 3 quarters · filed 2022-08-15 | $22.50M derived: sum of 4 quarters · filed 2022-08-15 | ||||||||||||
| 2021-03-31 | $4.90M 10-Q · filed 2022-05-16 | $11.27M derived: sum of 2 quarters · filed 2022-05-16 | $16.05M derived: sum of 3 quarters · filed 2022-05-16 | $20.73M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $11.15M derived: sum of 2 quarters · filed 2022-03-31 | $15.83M derived: sum of 3 quarters · filed 2022-03-31 | $17.98M 10-K · filed 2022-03-31 | ||||||||||||
| 2020-09-30 | $4.78M 10-Q · filed 2021-11-15 | $9.46M derived: sum of 2 quarters · filed 2021-11-15 | $11.61M 10-Q · filed 2021-11-15 | $15.40M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||
| 2020-06-30 | $4.68M 10-Q · filed 2021-08-16 | $6.83M 10-Q · filed 2021-08-16 | $10.62M derived: sum of 3 quarters · filed 2021-08-16 | $12.12M derived: sum of 4 quarters · filed 2021-08-16 | ||||||||||||
| 2020-03-31 | $2.14M 10-Q · filed 2021-05-17 | $5.94M derived: sum of 2 quarters · filed 2021-05-17 | $7.44M derived: sum of 3 quarters · filed 2021-05-17 | $8.96M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||
| 2019-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $5.30M derived: sum of 2 quarters · filed 2021-03-31 | $6.82M derived: sum of 3 quarters · filed 2021-03-31 | $7.47M 10-K · filed 2021-03-31 | ||||||||||||
| 2019-09-30 | $1.50M 10-Q · filed 2020-11-09 | $3.02M derived: sum of 2 quarters · filed 2020-11-09 | $3.67M 10-Q · filed 2020-11-09 | $4.86M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | $1.52M 10-Q · filed 2020-08-10 | $2.17M 10-Q · filed 2020-08-10 | $3.36M derived: sum of 3 quarters · filed 2020-08-10 | $4.87M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | $646.00K 10-Q · filed 2020-05-11 | $1.84M derived: sum of 2 quarters · filed 2020-05-11 | $3.34M derived: sum of 3 quarters · filed 2020-05-11 | $4.82M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2018-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.70M derived: sum of 2 quarters · filed 2020-03-16 | $4.17M derived: sum of 3 quarters · filed 2020-03-16 | $6.47M 10-K · filed 2020-03-16 | ||||||||||||
| 2018-09-30 | $1.50M 10-Q · filed 2019-11-12 | $2.98M derived: sum of 2 quarters · filed 2019-11-12 | $5.28M 10-Q · filed 2019-11-12 | $6.28M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||
| 2018-06-30 | $1.48M 10-Q · filed 2019-08-09 | $3.77M 10-Q · filed 2019-08-09 | $4.78M derived: sum of 3 quarters · filed 2019-08-09 | $8.28M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||
| 2018-03-31 | $2.30M 10-Q · filed 2019-05-10 | $3.30M derived: sum of 2 quarters · filed 2019-05-10 | $6.80M derived: sum of 3 quarters · filed 2019-05-10 | $10.25M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $4.50M derived: sum of 2 quarters · filed 2019-03-06 | $7.95M derived: sum of 3 quarters · filed 2019-03-06 | $11.72M 10-K · filed 2019-03-06 | ||||||||||||
| 2017-09-30 | $3.50M 10-Q · filed 2018-11-13 | $6.95M derived: sum of 2 quarters · filed 2018-11-13 | $10.72M 10-Q · filed 2018-11-13 | $14.15M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||||
| 2017-06-30 | $3.44M 10-Q · filed 2018-08-14 | $7.22M 10-Q · filed 2018-08-14 | $10.65M derived: sum of 3 quarters · filed 2018-08-14 | $13.94M derived: sum of 4 quarters · filed 2018-08-14 | ||||||||||||
| 2017-03-31 | $3.77M 10-Q · filed 2018-05-11 | $7.21M derived: sum of 2 quarters · filed 2018-05-11 | $10.49M derived: sum of 3 quarters · filed 2018-05-11 | $14.72M derived: sum of 4 quarters · filed 2018-05-11 | ||||||||||||
| 2016-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $6.72M derived: sum of 2 quarters · filed 2018-03-29 | $10.95M derived: sum of 3 quarters · filed 2018-03-29 | $15.32M 10-K · filed 2018-03-29 | ||||||||||||
| 2016-09-30 | $3.29M 10-Q · filed 2017-11-07 | $7.51M derived: sum of 2 quarters · filed 2017-11-07 | $11.89M 10-Q · filed 2017-11-07 | $14.81M derived: sum of 4 quarters · filed 2017-11-07 | ||||||||||||
| 2016-06-30 | $4.23M 10-Q · filed 2017-08-14 | $8.60M 10-Q · filed 2017-08-14 | $11.52M derived: sum of 3 quarters · filed 2017-08-14 | $15.98M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||
| 2016-03-31 | $4.38M 10-Q · filed 2017-05-15 | $7.29M derived: sum of 2 quarters · filed 2017-05-15 | $11.76M derived: sum of 3 quarters · filed 2017-05-15 | $14.36M derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||
| 2015-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $7.38M derived: sum of 2 quarters · filed 2017-03-28 | $9.98M derived: sum of 3 quarters · filed 2017-03-28 | $13.11M 10-K · filed 2017-03-28 | ||||||||||||
| 2015-09-30 | $4.46M 10-Q · filed 2016-11-08 | $7.06M derived: sum of 2 quarters · filed 2016-11-08 | $10.20M 10-Q · filed 2016-11-08 | $12.28M derived: sum of 4 quarters · filed 2016-11-08 | ||||||||||||
| 2015-06-30 | $2.60M 10-Q · filed 2016-08-09 | $5.74M 10-Q · filed 2016-08-09 | $7.82M derived: sum of 3 quarters · filed 2016-08-09 | $9.79M derived: sum of 4 quarters · filed 2016-08-09 | ||||||||||||
| 2015-03-31 | $3.14M 10-Q · filed 2016-05-10 | $5.22M derived: sum of 2 quarters · filed 2016-05-10 | $7.20M derived: sum of 3 quarters · filed 2016-05-10 | $8.79M derived: sum of 4 quarters · filed 2016-05-10 | ||||||||||||
| 2014-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $4.06M derived: sum of 2 quarters · filed 2016-03-15 | $5.65M derived: sum of 3 quarters · filed 2016-03-15 | $8.43M 10-K · filed 2016-03-15 | ||||||||||||
| 2014-09-30 | $1.98M 10-Q · filed 2015-11-09 | $3.57M derived: sum of 2 quarters · filed 2015-11-09 | $6.34M 10-Q · filed 2015-11-09 | $7.74M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-06-30 | $1.59M 10-Q · filed 2015-08-10 | $4.37M 10-Q · filed 2015-08-10 | $5.76M derived: sum of 3 quarters · filed 2016-03-15 | $6.95M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-03-31 | $2.77M 10-Q · filed 2015-05-11 | $4.17M derived: sum of 2 quarters · filed 2016-03-15 | $5.36M derived: sum of 3 quarters · filed 2016-03-15 | $6.71M derived: sum of 4 quarters · filed 2016-03-15 | $36.07M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $2.59M derived: sum of 2 quarters · filed 2016-03-15 | $3.94M derived: sum of 3 quarters · filed 2016-03-15 | $5.69M 10-K · filed 2016-03-15 | $33.30M 10-K · filed 2014-03-21 | |||||||||||
| 2013-09-30 | $1.19M 10-Q · filed 2014-11-10 | $2.54M derived: sum of 2 quarters · filed 2014-11-10 | $4.29M 10-Q · filed 2014-11-10 | $5.29M derived: sum of 4 quarters · filed 2015-03-18 | $31.90M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $1.35M 10-Q · filed 2013-08-14 | $3.10M 10-Q · filed 2014-08-07 | $4.10M derived: sum of 3 quarters · filed 2015-03-18 | $5.51M derived: sum of 4 quarters · filed 2015-03-18 | $30.71M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $1.75M 10-Q · filed 2014-05-13 | $2.75M derived: sum of 2 quarters · filed 2015-03-18 | $4.16M derived: sum of 3 quarters · filed 2015-03-18 | $5.38M derived: sum of 4 quarters · filed 2015-03-18 | $29.36M 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $2.41M derived: sum of 2 quarters · filed 2015-03-18 | $3.63M derived: sum of 3 quarters · filed 2015-03-18 | $4.53M 10-K · filed 2015-03-18 | $27.61M 10-K · filed 2013-03-29 | |||||||||||
| 2012-09-30 | $1.41M 10-Q · filed 2013-11-12 | $2.62M derived: sum of 2 quarters · filed 2013-11-12 | $3.52M 10-Q · filed 2013-11-12 | $4.39M derived: sum of 4 quarters · filed 2013-11-12 | $26.61M 10-Q · filed 2012-11-09 | |||||||||||
| 2012-06-30 | $1.22M 10-Q · filed 2013-08-14 | $2.12M 10-Q · filed 2013-08-14 | $2.98M derived: sum of 3 quarters · filed 2013-08-14 | $3.63M derived: sum of 4 quarters · filed 2013-08-14 | $25.20M 10-Q · filed 2012-08-10 | |||||||||||
| 2012-03-31 | $901.00K 10-Q · filed 2013-05-10 | $1.76M derived: sum of 2 quarters · filed 2013-05-10 | $2.42M derived: sum of 3 quarters · filed 2013-05-10 | $3.71M derived: sum of 4 quarters · filed 2013-05-10 | $23.98M 10-Q · filed 2012-05-11 | |||||||||||
| 2011-12-31 | $862.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $1.52M derived: sum of 2 quarters · filed 2013-03-29 | $2.81M derived: sum of 3 quarters · filed 2013-03-29 | $3.55M 10-K · filed 2013-03-29 | $23.08M 10-K · filed 2012-03-30 | |||||||||||
| 2011-09-30 | $655.00K 10-Q · filed 2012-11-09 | $1.95M derived: sum of 2 quarters · filed 2012-11-09 | $2.69M 10-Q · filed 2012-11-09 | $3.08M derived: sum of 4 quarters · filed 2012-11-09 | $22.22M 10-Q · filed 2011-11-10 | |||||||||||
| 2011-06-30 | $1.29M 10-Q · filed 2012-08-10 | $2.04M 10-Q · filed 2012-08-10 | $2.42M derived: sum of 3 quarters · filed 2012-08-10 | $2.74M derived: sum of 4 quarters · filed 2012-08-10 | $21.57M 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $744.00K 10-Q · filed 2012-05-11 | $1.13M derived: sum of 2 quarters · filed 2012-05-11 | $1.45M derived: sum of 3 quarters · filed 2012-05-11 | $1.68M derived: sum of 4 quarters · filed 2012-05-11 | ||||||||||||
| 2010-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $703.00K derived: sum of 2 quarters · filed 2012-03-30 | $937.00K derived: sum of 3 quarters · filed 2012-03-30 | $1.07M 10-K · filed 2012-03-30 | ||||||||||||
| 2010-09-30 | $313.00K 10-Q · filed 2011-11-10 | $547.00K derived: sum of 2 quarters · filed 2011-11-10 | $676.00K 10-Q · filed 2011-11-10 | |||||||||||||
| 2010-06-30 | $234.00K 10-Q · filed 2011-08-12 | $363.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |